Mai Ohba

916 total citations
16 papers, 727 citations indexed

About

Mai Ohba is a scholar working on Immunology, Molecular Biology and Public Health, Environmental and Occupational Health. According to data from OpenAlex, Mai Ohba has authored 16 papers receiving a total of 727 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Immunology, 3 papers in Molecular Biology and 3 papers in Public Health, Environmental and Occupational Health. Recurrent topics in Mai Ohba's work include Asthma and respiratory diseases (3 papers), Glaucoma and retinal disorders (2 papers) and Immune Response and Inflammation (2 papers). Mai Ohba is often cited by papers focused on Asthma and respiratory diseases (3 papers), Glaucoma and retinal disorders (2 papers) and Immune Response and Inflammation (2 papers). Mai Ohba collaborates with scholars based in Japan, United States and Switzerland. Mai Ohba's co-authors include Yoshinori Nimura, Iyoko Katoh, Chikashi Kawahara, Masuo Obinata, Chikashi Ishioka, Yoji Ikawa, Akira Nakagawara, Shuntaro Ikawa, Motonobu Osada and Ryunosuke Kanamaru and has published in prestigious journals such as Nature Medicine, PLoS ONE and Scientific Reports.

In The Last Decade

Mai Ohba

16 papers receiving 720 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Mai Ohba Japan 11 391 386 176 90 61 16 727
Fernando Abarzúa Japan 13 430 1.1× 119 0.3× 57 0.3× 73 0.8× 46 0.8× 23 710
Kaoru Toyama Japan 10 500 1.3× 233 0.6× 46 0.3× 53 0.6× 123 2.0× 34 817
Emily M. King United States 11 356 0.9× 94 0.2× 58 0.3× 110 1.2× 29 0.5× 16 589
Aytekin Akyol Türkiye 14 464 1.2× 313 0.8× 29 0.2× 91 1.0× 151 2.5× 40 964
Bhavani S. Kowtharapu Germany 15 368 0.9× 153 0.4× 28 0.2× 76 0.8× 160 2.6× 27 684
Thao Nguyen United States 11 431 1.1× 179 0.5× 23 0.1× 68 0.8× 58 1.0× 28 698
Nicole C. Smits United States 14 252 0.6× 99 0.3× 42 0.2× 109 1.2× 66 1.1× 18 537
Luigi Ombrato United Kingdom 10 388 1.0× 327 0.8× 29 0.2× 146 1.6× 177 2.9× 17 835
Jim McBride United States 15 362 0.9× 245 0.6× 23 0.1× 47 0.5× 96 1.6× 20 604
Eleni‐Kyriaki Vetsika Greece 15 239 0.6× 508 1.3× 63 0.4× 444 4.9× 111 1.8× 36 851

Countries citing papers authored by Mai Ohba

Since Specialization
Citations

This map shows the geographic impact of Mai Ohba's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mai Ohba with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mai Ohba more than expected).

Fields of papers citing papers by Mai Ohba

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mai Ohba. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mai Ohba. The network helps show where Mai Ohba may publish in the future.

Co-authorship network of co-authors of Mai Ohba

This figure shows the co-authorship network connecting the top 25 collaborators of Mai Ohba. A scholar is included among the top collaborators of Mai Ohba based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mai Ohba. Mai Ohba is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

16 of 16 papers shown
1.
Okuno, Toshiaki, Mai Ohba, Yuichiro Endo, et al.. (2021). Eicosanoid profiling in patients with complete form of pachydermoperiostosis carrying SLCO2A1 mutations. The Journal of Dermatology. 48(9). 1442–1446. 2 indexed citations
2.
Okuno, Toshiaki, Hiroki Fujii, Shintaro Makino, et al.. (2021). Up-regulation of cytosolic prostaglandin E synthase in fetal-membrane and amniotic prostaglandin E2 accumulation in labor. PLoS ONE. 16(4). e0250638–e0250638. 8 indexed citations
3.
Ono, Yosuke, Osamu Yoshino, Kuniyuki Kano, et al.. (2021). Sphingosine 1-Phosphate (S1P) in the Peritoneal Fluid Skews M2 Macrophage and Contributes to the Development of Endometriosis. Biomedicines. 9(11). 1519–1519. 22 indexed citations
4.
Koga, Tomoaki, F Sasaki, Kazuko Saeki, et al.. (2020). Expression of leukotriene B4 receptor 1 defines functionally distinct DCs that control allergic skin inflammation. Cellular and Molecular Immunology. 18(6). 1437–1449. 15 indexed citations
5.
Sawada, Jun‐ichi, et al.. (2019). Identification of benzo[d]pyrrolo[2,1-b]thiazole derivatives as CENP-E inhibitors. Biochemical and Biophysical Research Communications. 519(3). 505–511. 8 indexed citations
6.
Ohba, Mai, Kazuko Saeki, Tomoaki Koga, et al.. (2018). Profiling of bioactive lipids in different dendritic cell subsets using an improved multiplex quantitative LC-MS/MS method. Biochemical and Biophysical Research Communications. 504(3). 562–568. 11 indexed citations
7.
Okuno, Toshiaki, Miguel A. Gijón, Simona Zarini, et al.. (2018). Altered eicosanoid production and phospholipid remodeling during cell culture. Journal of Lipid Research. 59(3). 542–549. 17 indexed citations
8.
Sasaki, F, Tomoaki Koga, Mai Ohba, et al.. (2018). Leukotriene B4 promotes neovascularization and macrophage recruitment in murine wet-type AMD models. JCI Insight. 3(18). 28 indexed citations
9.
Lee, Hyeon‐Cheol, Mai Ohba, Kazuko Saeki, et al.. (2018). Dietary ω‐3 fatty acids alter the lipid mediator profile and alleviate allergic conjunctivitis without modulating T h 2 immune responses. The FASEB Journal. 33(3). 3392–3403. 25 indexed citations
10.
Koga, Tomoaki, Mai Ohba, Toshiaki Okuno, et al.. (2017). Non-steroidal anti-inflammatory drug delays corneal wound healing by reducing production of 12-hydroxyheptadecatrienoic acid, a ligand for leukotriene B4 receptor 2. Scientific Reports. 7(1). 13267–13267. 52 indexed citations
11.
Okuno, Toshiaki, Sophia Koutsogiannaki, Mai Ohba, et al.. (2017). Intravenous anesthetic propofol binds to 5‐lipoxygenase and attenuates leukotriene B 4 production. The FASEB Journal. 31(4). 1584–1594. 12 indexed citations
12.
Shoji, Hiromichi, Tomohiro Kitamura, Mai Ohba, et al.. (2017). Urinary prostaglandin D2 metabolite excretion during the first six months of life was significantly lower in breast‐fed than formula‐fed infants. Acta Paediatrica. 107(1). 95–100. 8 indexed citations
13.
Koga, Tomoaki, Kazuko Saeki, Yumiko Ishii, et al.. (2016). Leukotriene B4 receptor type 2 protects against pneumolysin-dependent acute lung injury. Scientific Reports. 6(1). 34560–34560. 23 indexed citations
14.
Koutsogiannaki, Sophia, Matthew M. Schaefers, Toshiaki Okuno, et al.. (2016). Prolonged exposure to volatile anesthetic isoflurane worsens the outcome of polymicrobial abdominal sepsis. Toxicological Sciences. 156(2). kfw261–kfw261. 35 indexed citations
15.
Ohba, Mai, Katsuhiko Nakashima, & Tôru Miyazaki. (2012). [An optimum method for generation of functional recombinant apoptosis inhibitor of macrophage (AIM) protein].. PubMed. 84(7). 588–91. 1 indexed citations
16.
Osada, Motonobu, Mai Ohba, Chikashi Kawahara, et al.. (1998). Cloning and functional analysis of human p51, which structurally and functionally resembles p53. Nature Medicine. 4(7). 839–843. 460 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026